The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy.
The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy.
复制标题
污名对阿片类药物使用障碍，阿片类药物治疗和政策患者的影响。
DOI：
10.2147/sar.s304566
复制
发表时间：
2022
影响因子：
1.8
通讯作者：
Nielsen S
中科院分区：
文献类型：
--
作者：
Cheetham A;Picco L;Barnett A;Lubman DI;Nielsen S
非法药物使用障碍是全世界最受歧视的健康状况，歧视是进入治疗和提供治疗的重大障碍。在阿片类药物相关危害急剧上升的背景下，我们必须了解耻辱感的驱动因素以及它如何影响阿片类药物使用障碍的治疗和政策。这篇叙述性综述的目的是讨论阿片类药物相关的耻辱感如何影响治疗提供和减少危害，并提供在社会和结构层面减少耻辱感的潜在策略。我们使用整合耻辱感规范影响框架（FINIS）从宏观（结构性耻辱感）、中观（公共耻辱感）和微观（内化耻辱感）层面确定阿片类药物相关耻辱感的来源。减少耻辱需要针对多个层面的战略，但解决将阿片类药物和其他物质使用障碍患者与主流社会隔离开来的法律、法规和规则中的不平等问题至关重要。
Illicit drug use disorders are the most stigmatised health conditions worldwide, and stigma acts as a meaningful barrier to treatment entry and treatment provision. In the context of dramatically rising opioid-related harms, it is critical that we understand the drivers of stigma and how it affects opioid use disorder treatment and policy. The aim of this narrative review is to discuss how opioid-related stigma impacts treatment provision and harm reduction, and provide potential strategies to reduce stigma at a social and structural level. We used the Framework for Integrating Normative Influences on Stigma (FINIS) to identify sources of opioid-related stigma at the macro (structural stigma), meso (public stigma) and micro (internalised stigma) levels. Reducing stigma requires strategies that target multiple levels, however addressing inequity in the laws, regulations, and rules that segregate people with opioid and other substance use disorders from mainstream society is essential.